Synonyms: compound 2 [PMID: 32134643] | example 1 [WO2018112379A1] | JNJ-64251330 | JNJ64251330
Compound class:
Synthetic organic
Comment: The chemical structure that was submitted to the WHO for the INN lorpucitinib is identical to the structure of example 1 that is claimed as a pan-Janus kinase inhibitor in Janssen's patent WO2018112379A1 [1]. Based on structural conformation this is an exact match to PubChem SID 395564298, and this is associated to CID 134611548. However, this CID does not specify the stereochemical conformation as described in the patent or as stipulated in the INN submission. The chemical structure was disclosed in March 2020 as a JAK inhibitor that is intended for the treatment of inflammatory bowel disease [2]. Its activity is restricted to the gut by virtue of its permeability and physicochemical properties, and this limits systemic exposure and the potential for on-target adverse events. Lorpucitinib is Janssen's clinical lead JNJ-64251330. It blocks phosphorylation and activation of Signal Transducer and Activator of Transcription (STAT) factor proteins.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
2-{1-[trans-4-(cyanomethyl)cyclohexyl]-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2-yl}-N-(2-hydroxy-2-methylpropyl)acetamide |
International Nonproprietary Names | |
INN number | INN |
11296 | lorpucitinib |
Synonyms |
compound 2 [PMID: 32134643] | example 1 [WO2018112379A1] | JNJ-64251330 | JNJ64251330 |
Database Links | |
GtoPdb PubChem SID | 404859078 |
PubChem CID | 134611548 |
Search Google for chemical match using the InChIKey | NJKMSBSVJSQUBU-SHTZXODSSA-N |
Search Google for chemicals with the same backbone | NJKMSBSVJSQUBU |
Search PubMed clinical trials | lorpucitinib |
Search PubMed titles | lorpucitinib |
Search PubMed titles/abstracts | lorpucitinib |
UniChem Compound Search for chemical match using the InChIKey | NJKMSBSVJSQUBU-SHTZXODSSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | NJKMSBSVJSQUBU-SHTZXODSSA-N |